Joseph M. Connors
0000-0002-1361-7531
Publication & Citation Trends
Publications
786 total
Seven-year overall survival analysis from ECHELON-1 study of A+AVD versus ABVD in patients with previously untreated stage III/IV classical Hodgkin lymphoma.
Cited by 3
Semantic Scholar
Frontline therapy with bendamustine rituximab (BR) and rituximab cyclophosphamide vincristine prednisone (RCVP) confers similar long-term outcomes in patients with treatment naïve Waldenström macroglobulinemia in a real-world setting: a population-based analysis
Cited by 2
Semantic Scholar
P007: Comparative efficacy of the R-BEACOPP-14 and R-CHOP regimens in the treatment of patients with advanced stages of nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) with THRLBCL-like histopathological growth patterns in the tumor biopsy OA
Cited by 0
Semantic Scholar
EXPLORATORY BIOMARKER ANALYSIS IN THE PH 3 ECHELON‐1 STUDY: WORSE OUTCOME WITH ABVD IN PATIENTS WITH ELEVATED BASELINE LEVELS OF SCD30 AND TARC OA
Cited by 1
Semantic Scholar
PROGNOSTIC FACTORS IN PATIENTS WITH RELAPSED OR REFRACTORY SYSTEMIC ANAPLASTIC LARGE T‐CELL LYMPHOMA (ALCL) RECEIVING BRENTUXIMAB VEDOTIN AND OUTCOME AFTER TREATMENT FAILURE. OA
Cited by 1
Semantic Scholar
Secondary Breast Cancer Risk by Radiation Volume in Women With Hodgkin Lymphoma.
Cited by 13
Semantic Scholar
Session 15: Hodgkin lymphoma 159 GENETIC POLYMORPHISMS INFLUENCE THE RISK OF HODGKIN’S LYMPHOMA OA
Cited by 1
Semantic Scholar
Research Topics
Lymphoma Diagnosis and Treatment
(654)
Chronic Lymphocytic Leukemia Research
(193)
Viral-associated cancers and disorders
(162)
CNS Lymphoma Diagnosis and Treatment
(138)
Lung Cancer Treatments and Mutations
(90)
Affiliations
University of Notre Dame
Ontario Institute for Cancer Research
Oslo University Hospital
BC Cancer Agency
Biogen (United States)